Sorry you feel that way. I consider my Catholic s
Post# of 11802
None of that matters with the GenUltimate TBG! It was created by a product of the Indianapolis public schools and the very secular Indiana University.
If the product as I have reviewed it can be manufactured in quantity and at a commercial price the there is a good chance that GenUltimate! TBG can become one of the 10 best medical devices ever sold. The product comes along at the right time, just as the market is seeing the first green shoots of a change in technology. TBG is a product life-cycle curve tweeker. A BIG ONE. It will provide 4 million worldwide Lifescan OneTouch users a path to upgrade while using essentially the same product many of them have for 15 or more years.
TBG should also blunt the Chinese systems invasion, something Roche, Bayer and Abbott have not been able to do. Oh yes, the remaining three of the Big 4 have taken away Lifescan users but the Chinese products have done a better job of it. There are almost 2 million former Lifescan users who have switched meters since 2012. In fact there are more former Lifescan users than there are any company's total users, except Roche. The peak of Lifescan Ultra as the #1 product on the market was 5.9 million users worldwide. Some/many of these former users would come back if their beloved Ultra meters could only be upgraded. Some in the EU cannot come back to their beloved Ultra meters because of punitive regulations. GenUltimate! TBG fixes that problem.
Something also subtle here. While the DECN business proposition has been to make better directly competing strips that would offer the same thing cheaper for legacy systems users, the company now has a product that changes its equation. Let's see if KB and his Koreans can make the product work and be approved in the new FDA environment and if he can make the test strip at a price that allows him to retail price GenUltimate! TBG at $0.25 per test strip. $0.25 per test strip, IMO, using an analogy is the same as $2.00 per gallon gasoline in the U.S. If he does that then he has made a great leap in technology and will have created probably the last great mousetrap in the at-home testing market.
But I still get it. It doesn't really matter what KB has done or does, it remains all about today's share price, today's trading, today's news releases, all of which about 2% of current shareholders have found lacking to a greater or more greater degree. You know that crowd, we all do.
And in closing, this little debate about "TBG" is just another example of lay people without a shred of industry or product experience do to the company they supposedly own a stake in. Why would any CEO want to work for you guys?